Investment Stage

Focus Areas

About Investor

Miyuki Matsumoto is the Managing Partner and Head of US Investments at Aglaé Ventures who focuses on investments in Wellness & Fitness, Space, Consumer Health, Web3/Crypto, and BioTech, primarily at Series A and Series B stages with investment ranges typically between $100K and $100.0M. Her verified work background includes prior experience at Goldman Sachs as a Managing Director in Venture Capital, Growth Equity, and Hedge Funds. Matsumoto has successfully invested in notable companies like SpaceX and ATAI Life Sciences, demonstrating a track record of strategic partnerships and capital raising. She holds an MBA from The Wharton School and has expertise in alternative investments, asset management, and financial modeling.